Molina Healthcare, Inc. (MOH)

Molina Healthcare Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Molina Healthcare stock have an average target of 359.64, with a low estimate of 297 and a high estimate of 406. The average target predicts an increase of 7.51% from the current stock price of 334.52.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$297	$359.64	$372	$406
Change	-11.22%	+7.51%	+11.20%	+21.37%

Analyst Ratings

The average analyst rating for Molina Healthcare stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	2	2
Buy	4	3	3	3	5	4
Hold	6	7	6	8	7	9
Sell	1	1	1	1	1	0
Strong Sell	0	0	0	0	0	0
Total	13	13	12	14	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Ha Baird	Baird	Buy → Hold Downgrades $331 → $375	Buy → Hold	Downgrades	$331 → $375	+12.10%	Apr 15, 2025
David Macdonald Truist Securities	Truist Securities	Strong Buy Maintains $340 → $400	Strong Buy	Maintains	$340 → $400	+19.57%	Apr 11, 2025
Jason Cassorla Guggenheim	Guggenheim	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Apr 9, 2025
Ann Hynes Mizuho	Mizuho	Buy Maintains $376 → $400	Buy	Maintains	$376 → $400	+19.57%	Apr 9, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Hold → Buy Upgrades $295 → $372	Hold → Buy	Upgrades	$295 → $372	+11.20%	Mar 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

44.29B

Increased by 13.09%

from 39.16B

Revenue Next Year

47.81B

Increased by 7.95%

from 44.29B

EPS This Year

24.52

Increased by 20.06%

from 20.42

EPS Next Year

28.37

Increased by 15.71%

from 24.52

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	18.38B	26.98B	31.10B	33.00B	39.16B	44.29B	47.81B	51.49B
Revenue Growth	12.45%	46.85%	15.26%	6.12%	18.67%	13.09%	7.95%	7.70%
EPS	11.23	11.25	13.55	18.77	20.42	24.52	28.37	32.48
EPS Growth	-2.09%	0.18%	20.44%	38.52%	8.79%	20.06%	15.71%	14.50%
Forward PE	-	-	-	-	-	13.64	11.79	10.30
No. Analysts	-	-	-	-	-	18	18	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	46.8B	51.0B	56.9B
Avg	44.3B	47.8B	51.5B
Low	40.9B	44.0B	47.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	19.6%	15.2%	19.1%
Avg	13.1%	7.9%	7.7%
Low	4.3%	-0.7%	0.3%

EPS Forecast

EPS	2025	2026	2027	2028
High	25.88	32.55	37.38
Avg	24.52	28.37	32.48
Low	21.46	26.55	29.89

EPS Growth

EPS Growth	2025	2026	2027	2028
High	26.8%	32.8%	31.8%
Avg	20.1%	15.7%	14.5%
Low	5.1%	8.3%	5.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.